Verona Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Verona Pharma and other ETFs, options, and stocks.

About VRNA

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. 

CEO
David S. Zaccardelli
CEODavid S. Zaccardelli
Employees
209
Employees209
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2005
Founded2005
Employees
209
Employees209

VRNA Key Statistics

Market cap
5.82B
Market cap5.82B
Price-Earnings ratio
-31.80
Price-Earnings ratio-31.80
Dividend yield
—
Dividend yield—
Average volume
1.05M
Average volume1.05M
High today
$77.47
High today$77.47
Low today
$75.03
Low today$75.03
Open price
$66.09
Open price$66.09
Volume
76.17K
Volume76.17K
52 Week high
$77.47
52 Week high$77.47
52 Week low
$11.39
52 Week low$11.39

VRNA News

TipRanks 24h
Verona Pharma’s Promising Outlook: Buy Rating Backed by Strong Ohtuvayre Sales and Strategic Positioning

Canaccord Genuity analyst Edward Nash maintained a Buy rating on Verona Pharma (VRNA – Research Report) yesterday and set a price target of $72.00. Edward Nash...

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.